CWM
CGTX icon

Circle Wealth Management’s Cognition Therapeutics CGTX Stock Holding History

Circle Wealth Management’s Portfolio CGTX Stock Details CGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$56.2K Hold
48,842
– – ﹤0.01% 255
2026
Q1 		$37.1K Hold
48,842
– – ﹤0.01% 263
2025
Q4 		$65.9K Hold
48,842
– – ﹤0.01% 241
2025
Q3 		$65.9K Hold
48,842
– – ﹤0.01% 224
2025
Q2 		$15.1K Hold
48,842
– – ﹤0.01% 220
2025
Q1 		$20.6K Hold
48,842
– – ﹤0.01% 216
2024
Q4 		$34.3K Hold
48,842
– – ﹤0.01% 214
2024
Q3 		$22.9K Hold
48,842
– – ﹤0.01% 213
2024
Q2 		$81.1K Hold
48,842
– – ﹤0.01% 212
2024
Q1 		$88.9K Buy
+48,842
New +$101K ﹤0.01% 193

Other funds holding CGTX

BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.17B AUM 42.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.47B AUM 18.73% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Circle Wealth Management's CGTX Position: Q2 2026 in Review

Circle Wealth Management held its Cognition Therapeutics (CGTX) position steady in Q2 2026 at 48,842 shares worth $56.2K. The position accounts for ﹤0.01% of the portfolio, ranked #255.

Circle Wealth Management first reported a position in CGTX in Q1 2024 and has held it in 10 quarters since. The position peaked at $88.9K in Q1 2024. 66 funds tracked by Wall St. Rank hold CGTX as of Q2 2026.

  • Circle Wealth Management held 48,842 shares of Cognition Therapeutics worth $56.2K as of Q2 2026.
  • Circle Wealth Management left its Cognition Therapeutics share count unchanged in Q2 2026.
  • Cognition Therapeutics made up ﹤0.01% of Circle Wealth Management's portfolio in Q2 2026, its #255 holding.
  • Circle Wealth Management first reported a position in Cognition Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • Circle Wealth Management's Cognition Therapeutics position peaked at $88.9K in Q1 2024.
  • 66 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q2 2026.

Based on Circle Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.